WA HB 1034
died on adjournmentConcerning nonopioid drugs for the treatment of pain.
Washington · 2026 Regular Session · lower
Quick answers
Did WA HB 1034 pass?
No. WA HB 1034 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-01-12): By resolution, reintroduced and retained in present status.
What is WA HB 1034 about?
WA HB 1034 is a bill in the 2026 Regular Session titled “Concerning nonopioid drugs for the treatment of pain.”.
Who sponsors WA HB 1034?
Ortiz-Self is the primary sponsor of WA HB 1034, joined by 7 cosponsors.
- Introduced
- —
- Latest action
- 2026-01-12 — By resolution, reintroduced and retained in present status.
- Bill type
- bill
- Last updated
- —
Sponsors
- Ortiz-Selfprimary
- Donaghycosponsor
- Lekanoffcosponsor
- Ormsbycosponsor
- Hillcosponsor
- Simmonscosponsor
- Petersoncosponsor
- Klobacosponsor
Committees
Not provided by source.
Action timeline
2024-12-11
Prefiled for introduction.
filing
2025-01-13
First reading, referred to Health Care & Wellness.
reading-1,referral-committee
2025-01-21
Public hearing in the House Committee on Health Care & Wellness at 1:30 PM.
2026-01-12
By resolution, reintroduced and retained in present status.
Versions
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:37:10.718715Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=WA&identifier=HB 1034. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.